PloS one, 2013-09, Vol.8 (9), p.e72999-e72999
2013
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα)
- Ist Teil von
- PloS one, 2013-09, Vol.8 (9), p.e72999-e72999
- Ort / Verlag
- United States: Public Library of Science
- Erscheinungsjahr
- 2013
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Estrogens and tamoxifen (an antiestrogen) exert their actions by activation of estrogen receptor (ER) through genomic and non-genomic mechanisms and are implicated in the development of endometrial cancer. Previous reports have demonstrated that estradiol and tamoxifen induce proliferation of human endometrial cancer cells through GPR30 (non-genomic ER) signaling pathway. Herein, we demonstrate that phosphorylation of focal adhesion kinase (FAK) is involved in cell migration induced by estradiol, tamoxifen and G1 (a GPR30 agonist) through the transmembrane ER (GPR30) in endometrial cancer cell lines with or without ERα (Ishikawa and RL95-2). Additionally, the GPR30-mediated cell migration was further abolished by administration of either specific RNA interference targeting GPR30 or an FAK inhibitor. Moreover, we have validated that the signaling between GPR30 and phosphorylated FAK is indeed mediated by the EGFR/PI3K/ERK pathway. Clinically, a significant correlation between levels of GPR30 and phophorylated FAK (pFAK) observed in human endometrial cancer tissues with low or without ERα further suggested that estrogen-induced phosphorylation of FAK and cell migration were most likely triggered by GPR30 activation. These results provided new insights for understanding the pathophysiological functions of GPR30 in human endometrial cancers.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1932-6203eISSN: 1932-6203DOI: 10.1371/journal.pone.0072999Titel-ID: cdi_plos_journals_1431102559
- Format
- –
- Schlagworte
- 1-Phosphatidylinositol 3-kinase, 17β-Estradiol, Activation, Adhesion, Antiestrogens, Cancer, Cell adhesion & migration, Cell growth, Cell Line, Tumor, Cell migration, Cell Movement - drug effects, Cell proliferation, Cell Proliferation - drug effects, Endometrial cancer, Endometrial Neoplasms - genetics, Endometrial Neoplasms - metabolism, Endometrium, Epidermal growth factor receptors, ErbB Receptors - metabolism, Estradiol - pharmacology, Estrogen Receptor alpha - metabolism, Estrogen receptors, Estrogens, Extracellular signal-regulated kinase, Extracellular Signal-Regulated MAP Kinases - metabolism, Female, Focal adhesion kinase, Focal Adhesion Protein-Tyrosine Kinases - metabolism, Gene Expression, Humans, Kinases, Metabolic pathways, Phosphatidylinositol 3-Kinases - metabolism, Phosphorylation, Phosphorylation - drug effects, Receptors, Estrogen - genetics, Receptors, Estrogen - metabolism, Receptors, G-Protein-Coupled - genetics, Receptors, G-Protein-Coupled - metabolism, Ribonucleic acid, RNA, RNA-mediated interference, Sex hormones, Signal transduction, Signal Transduction - drug effects, Signaling, src-Family Kinases - metabolism, Tamoxifen, Tamoxifen - pharmacology, Tissues, Tumor cell lines, Tyrosine - metabolism, Uterine cancer